MINNEAPOLIS – November 7, 2019 – Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state cannabis company, today announced that it has named Bruce Linton to the role of Executive Chairman. As Executive Chairman, Mr. Linton will be actively involved in the Company’s business. He will serve on the board of directors, work closely with Vireo CEO & Founder Kyle Kingsley, M.D., and spearhead the Company’s strategic decision-making, capital markets activity and future partnerships....
Read moreTotal revenue of $7.2 million increased 70 percent year-over-year – – Voluntary share lock-up extensions approved by management and insiders – – Christian Gonzalez promoted to Vice President of enterprise-wide...
Read moreMINNEAPOLIS – June 20, 2019 – Vireo Health International, Inc. (“Vireo” or the “Company”) (CSE: VREO), a leading physician-led, science-focused multi-state cannabis company, today announced the acquisition of medical cannabis...
Read moreRabin brings two decades of marketing and innovation experience in consumer healthcare and beverage alcohol industries NEW YORK, May 28, 2019 – Vireo Health International, Inc., a leading science-focused, multi-state...
Read moreCompany establishes U.S. governance standards with appointment of new directors and committees MINNEAPOLIS — May 16, 2019 – Vireo Health International, Inc. ("Vireo Health" or the "Company") (CSE: VREO), a...
Read more